Fitzpatrick Alexander A
SEC CIK 1398595 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | CLO | 90.9K | $319.7K | $1.49M | 4 | 2023-09-28 | 2026-06-12 |
Most active insiders at SPRY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chakma Justin | Chief Business Off | — | $1.48M |
| 2 | Karas Eric | Chief Commercial Off | — | $250.0K |
| 3 | Dorsey Brian | COO | — | $190.1K |
| 4 | Fitzpatrick Alexander A | CLO | — | $33.5K |
| 5 | Shah Pratik | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-12 20:04 | 2026-06-12 | SPRY | ARS Pharmaceuticals, Inc. | Fitzpatrick Alexander A | CLO | S - Sale | $10.00 | -3,355 | 90.9K | -4% | -$33.5K |
| D | 2025-05-22 | 2025-05-20 | SPRY | ARS Pharmaceuticals, Inc. | Fitzpatrick Alexander A | CLO | M - OptEx | $5.58 | +100.0K | 192.6K | +108% | +$558.0K |
| D | 2025-05-22 | 2025-05-20 | SPRY | ARS Pharmaceuticals, Inc. | Fitzpatrick Alexander A | CLO | S - Sale+OE | $14.10 | -103.0K | 89.6K | -53% | -$1.45M |
| M | 2023-10-02 | 2023-09-28+ | SPRY | ARS Pharmaceuticals, Inc. | Fitzpatrick Alexander A | CLO | P - Purchase | $3.71 | +86.3K | 43.0K | New | +$319.7K |
Purchase Sale Sale after option exercise All abbreviations